β-Cells Different Vulnerability to the Parkinsonian Neurotoxins Rotenone, 1-Methyl-4-phenylpyridinium (MPP+) and 6-Hydroxydopamine (6-OHDA).
Marco CarliFrancesca VagliniEleonora RisalitiGianluca CitiMatilde MasiniShivakumar KolachalamRoberto MaggioGiovanni Umberto CorsiniMichela NovelliVincenzo De TataMarco ScarselliPublished in: Pharmaceuticals (Basel, Switzerland) (2021)
Neurotoxins such as rotenone, 1-methyl-4-phenylpyridinium (MPP+) and 6-hydroxydopamine (6-OHDA) are well known for their high toxicity on dopaminergic neurons and are associated with Parkinson's disease (PD) in murine models and humans. In addition, PD patients often have glucose intolerance and may develop type 2 diabetes (T2D), whereas T2D patients have higher risk of PD compared to general population. Based on these premises, we evaluated the toxicity of these three toxins on pancreatic β-cell lines (INS-1 832/13 and MIN6) and we showed that rotenone is the most potent for reducing β-cells viability and altering mitochondrial structure and bioenergetics in the low nanomolar range, similar to that found in dopaminergic cell lines. MPP+ and 6-OHDA show similar effects but at higher concentration. Importantly, rotenone-induced toxicity was counteracted by α-tocopherol and partially by metformin, which are endowed with strong antioxidative and cytoprotective properties. These data show similarities between dopaminergic neurons and β-cells in terms of vulnerability to toxins and pharmacological agents capable to protect both cell types.
Keyphrases
- induced apoptosis
- type diabetes
- oxidative stress
- cell cycle arrest
- ejection fraction
- newly diagnosed
- spinal cord
- stem cells
- prognostic factors
- cardiovascular disease
- climate change
- endoplasmic reticulum stress
- cell death
- metabolic syndrome
- signaling pathway
- adipose tissue
- patient reported outcomes
- skeletal muscle
- cell proliferation
- electronic health record
- big data
- drug induced
- weight loss
- glycemic control
- pi k akt
- artificial intelligence